Melrose rewards shareholders as aerospace demand hits new heights

Melrose reported a strong 2025 with revenue up 8% to £3.59bn and adjusted operating profit rising 23% to £647m (adjusted margin +240bps to 18%). Adjusted PBT was £515m and adjusted diluted EPS rose 25% to 32.1p; free cash flow after interest and tax improved to £125m and net debt was £1.41bn (1.8x leverage). The board increased the full-year dividend 20% to 7.2p and launched a £175m buyback, while issuing 2026 guidance of revenue £3.75–3.95bn, adjusted operating profit £700–750m and FCF £150–200m, reflecting continued engines and defence-driven momentum and material upside to returns.

Analysis

Market structure: Melrose (MRO.L / OTC:MLSPF) is a clear winner within aerospace suppliers — 8% revenue growth, 240bp margin expansion and leverage at 1.8x imply improved pricing power and better cash conversion (FCF £125m, guidance £150–200m for 2026). OEMs (Airbus AIR.PA, Boeing BA) and aftermarket suppliers benefit from higher engine and defence production; commodity suppliers (aluminium, titanium) will see modest demand lift. Legacy weak players or pure civil-focused airframe vendors face margin pressure if defence ramps and aftermarket shift value capture.

Risk assessment: Key tail risk is reversal of the £324m RRSP variable consideration or an OEM production shock (Boeing/Airbus delivery stall) — a 20–30% swing in variable consideration would cut Engines profit materially. Near-term risk: H1 cash weighted profile (profit/cash backloaded) means 0–3 month volatility if orders or deliveries slip; medium-term (6–18 months) execution on buyback and transformation is the main idiosyncratic risk. Hidden dependency: profitability tied to RRSP contract accounting and aftermarket growth assumptions; regulation/pension liabilities remain a downside if macro tightens.

Trade implications: Core long in MRO is warranted given 2026 guide (adj OP £700–750m) and buyback £175m — implied TSR upside 20–30% over 12 months if execution holds. Use hedged pair exposure vs Rolls‑Royce (RR.L) to isolate execution spread: long MRO, short RR.L sized 1:0.8. Options: buy mezzanine call exposure (9–12 month call spreads) sized small (≤1% NAV) to capture convexity into production ramp confirmations and FY1H updates.

Contrarian angles: Consensus may underappreciate concentration in RRSP variable consideration; if that reverses, downside could be >25% despite buybacks. Conversely, market may underprice sustainable margin upside in Engines (31.9% margin) and aftermarket; if defence budgets and OEM ramps accelerate, multiple expansion is possible — target re-rating if net debt/EBITDA falls below 1.5x by mid‑2027. Watch orderbook, RRSP cash realization, and H1 revenue cadence as unexpected catalysts.

Key Decisions for Investors

• Establish a 2–3% NAV long position in Melrose Industries (MRO.L / MLSPF OTC) on any pullback up to 5% from current levels; target 12‑month total return +25%, set stop-loss at -12% or if reported 1H26 FCF < £60m or 2026 guidance is trimmed below the lower bounds (£3.75bn revenue or £700m adj OP).
• Implement a directional, limited-risk options trade: purchase 9–12 month MRO call spreads sized ≤1% NAV (buy nearer‑ATM call, sell 20–30% OTM call) to capture upside to buyback and margin delivery while capping premium outlay; close on confirmation of H1 production ramps or if implied vol rises >40% from current levels.
• Enter a relative-value pair trade: long MRO.L 2% NAV vs short Rolls‑Royce (RR.L) 1.5% NAV to hedge aerospace-cycle beta and express conviction in Melrose’s restructuring execution; rebalance quarterly or exit if spread (MRO vs RR total return) narrows/widens by >15 percentage points.
• Rotate 1–2% NAV into aerospace & defence exposure (e.g., ITA) funded by reducing cyclicals exposure (autos or consumer discretionary) by similar amount; increase if sector credit spreads compress >100bps or MRO net debt/EBITDA falls below 1.5x by next two quarters.